SCHEMBL14469633

SCHEMBL14469633

C=C(N)/C=C(\C=C/N)CN1CCC(C(=O)N2CCN(Cc3ccc(F)cc3S(=O)(=O)N(C)C)CC2)CC1

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ MTNR1B P49286 1/20 0.37
▸ KDM4E B2RXH2 4/20 0.35
▸ RORC P51449 2/20 0.35
▸ GPR6 P46095 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ ALOX15 P16050 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14469256 0.90 ALDH1A1 (0.38) ALDH1A1TDP1MTNR1BKDM4ERORC
SCHEMBL14469186 0.87 ALDH1A1 (0.47) ALDH1A1TDP1MTNR1BKDM4EGPR6
SCHEMBL14469187 0.85 MEN1 (0.43) ALDH1A1TDP1MTNR1BKDM4ESMN1; SMN2
SCHEMBL14469294 0.84 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2KMT2AMEN1TSHR
SCHEMBL14469182 0.81 ALDH1A1 (0.48) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL14469183 0.81 ALDH1A1 (0.39) ALDH1A1KDM4ERORCSMN1; SMN2KMT2A
SCHEMBL14469580 0.80 L3MBTL1 (0.41) ALDH1A1SMN1; SMN2MAPTTSHR
SCHEMBL14469170 0.79 KDM4E (0.48) ALDH1A1MTNR1BKDM4EGPR6SMN1; SMN2
SCHEMBL14469298 0.78 MEN1 (0.47) ALDH1A1KDM4ESMN1; SMN2KMT2AMEN1
SCHEMBL14469193 0.78 POLB (0.43) ALDH1A1SMN1; SMN2KMT2AMEN1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007075555-A2 COMBINATION OF AN H3 ANTAGONIST/INVERSE AGONIST AND AN APPETITE SUPPRESSANT SCHERING CORPORATION (US) 2007-07-05 — — WO disclosed
Send feedback